ABSORPTION OF BUPIVACAINE FROM THE PRE-PERITONEAL SPACE IN LAPAROSCOPIC HERNIA REPAIR

被引：3

作者：

DEANS, GT ^{[1
]}

RICHARDSON, T ^{[1
]}

WILSON, MS ^{[1
]}

BROUGH, WA ^{[1
]}

机构：

[1] STEPPING HILL HOSP,STOCKPORT UNIT MINIMALLY INVAS THERAPY,STOCKPORT SK2 7JE,ENGLAND

来源：

MINIMALLY INVASIVE THERAPY | 1995年 / 4卷 / 03期

关键词：

LAPAROSCOPIC HERNIA REPAIR; ANALGESIA; BUPIVACAINE;

D O I：

10.3109/13645709509153050

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Local anaesthetic placed into the pre-peritoneal space during laparoscopic hernia repair may provide additional pain relief, reducing the requirement for post-operative analgesia. The systemic absorption of such drugs from this space has not previously been determined. Twenty patients undergoing laparoscopic transperitoneal hernia repair were randomly allocated to receive bupivacaine 1.5 mg/kg or bupivacaine 1.5 mg/kg with 1.200 000 adrenaline. Venous blood samples were obtained at 10, 15, 30, 60 and 90 min following instillation of bupivacaine. Plasma levels of bupivacaine at these times were determined using high pressure gas liquid chromatography. No patient experienced signs or symptoms of bupivacaine toxicity. Mean plasma concentrations of bupivacaine peaked at 30 min and did not reach toxic levels. The addition of adrenaline did not significantly alter the systemic absorption of bupivacaine. Instilling bupivacaine 1.5 mg/kg into the pre-peritoneal space is associated with a low risk of toxicity. The addition of adrenaline is unnecessary and can be omitted from further trials. This information should facilitate the study of post-operative analgesia requirements following laparoscopic hernia repair.

引用

页码：175 / 177

页数：3

共 15 条

[1]

Wilson M.S., Deans G.T., Brough W.A., A prospective trial of Lichtenstein and laparoscopic tension-free mesh inguinal hernia repairs, Br J Surg, 82, pp. 274-277, (1995)

[2]

Guidelines for Day Case Surgery., (1992)

[3]

Patel J.M., Lanzafame R.J., Williams J.S., Mullen B.V., Hinshaw J.R., The effect of incisional infiltration of bupivacaine hydrochloride upon pulmonary functions, atelectasis and narcotic need following elective cholecystectomy, Surg Gynecol Obstet, 157, pp. 338-340, (1983)

[4]

Mos G., Regal M.E., Lichtig L., Reducing postoperative pain, narcotics and length of hospitalization, Surgery, 99, pp. 206-210, (1986)

[5]

Cook P., Lambert T., An investigation of the effectiveness of bupivacaine applied to the abdominal wall and fallopian tubes in reducing pain after laparoscope tubal ligation, Anaesth Intensive Care, 14, pp. 148-151, (1986)

[6]

Narchi P., Benhamou D., Fernandez H., Intra-peritoneal local anaesthetic for shoulder pain after day-case laparoscopy, Lancet, 338, pp. 1569-1570, (1991)

[7]

Thiry E., Paris P., Weerts J., Joris J., Intraperitoneal bupivacaine does not reduce postoperative pain after laparoscopic cholecystectomy, Br J Anaes, 72, (1994)

[8]

Rademaker B., Kalkman C., Odoom J., de Wit L., Ringers J., Intraperitoneal local anaesthetics after laparoscopic cholecystectomy: effects on postoperative pain, metabolic responses and lung function, Br J Anaes, 72, pp. 263-266, (1994)

[9]

Scott D., Evaluation of the toxicity of local anaesthetic agents in man, Br J Anaes, 47, pp. 56-61, (1975)

[10]

Kastrissios H., Triggs E.J., Sinclair F., Moran P., Smithers M., Plasma concentrations of bupivacaine after wound infiltration of a 0.5% solution after inguinal herniorrhaphy: a preliminary study, Eur J Clin Pharmacol, 44, pp. 555-557, (1993)

← 1 2 →